| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
michael_kent_ranson [2022/07/26 00:47]
liam [World Health Organization] | michael_kent_ranson [2023/04/23 06:13] (current)
liam |
|---|
| ==== Education ==== | ==== Education ==== |
| |
| Ranson holds an MD from [[McMaster University]], an MPH from the [[Harvard School of Public Health]], and a DPhil in health economics and financing from the [[London School of Hygiene and Tropical Medicine]].((//Michael Kent Ranson.// (2021, October 22). Gavi, the Vaccine Alliance. https://archive.ph/sMv3m)) | Ranson holds an MD from [[McMaster University]], an MPH from the [[Harvard School of Public Health]], and a DPhil in health economics and financing from the [[London School of Hygiene and Tropical Medicine]].((//Michael Kent Ranson.// (2021, October 22). Gavi, the Vaccine Alliance. http://archive.today/2022.07.25-215508/https://www.gavi.org/governance/gavi-board/members/michael-kent-ranson)) |
| |
| ===== Career ===== | ===== Career ===== |
| Later, at the [[World Health Organization]], he supported health policy and systems research and led the secretariat for the First and Second [[Global Symposium on Health Systems Research]] under [[Health Systems Global]].((Milko, E., Wu, D., Neves, J., Neubecker, A. W., Lavis, J., & Ranson, M. K. (2014). //Second Global Symposium on Health Systems Research: a conference impact evaluation.// Health Policy and Planning, 30(5), 612–623. https://doi.org/10.1093/heapol/czu040)) | Later, at the [[World Health Organization]], he supported health policy and systems research and led the secretariat for the First and Second [[Global Symposium on Health Systems Research]] under [[Health Systems Global]].((Milko, E., Wu, D., Neves, J., Neubecker, A. W., Lavis, J., & Ranson, M. K. (2014). //Second Global Symposium on Health Systems Research: a conference impact evaluation.// Health Policy and Planning, 30(5), 612–623. https://doi.org/10.1093/heapol/czu040)) |
| |
| The second symposium was sponsored by [[Abt Associates]], the [[Alliance for Health Policy and Systems Research]], [[Brazilian Ministry of Health]], [[British Medical Journal]] (BMJ), [[China Medical Board]], [[Doris Duke Charitable Foundation]], [[German Federal Ministry for Economic Cooperation and Development]] (BMZ), [[Global Health Research Initiative]], [[International Development Research Centre]], [[Management Sciences for Health]], [[Ministry of Health of the People's Republic of China]], [[Norwegian Agency for Development Cooperation]] (Norad), [[pharmaceutical_companies:Novartis]], [[Open Society Foundations]], [[Results for Development Institute]], [[Rockefeller Foundation]], [[Sightsavers]], [[Spanish Ministry of Foreign Affairs and Cooperation]], [[Special Programme of Research, Development and Research Training in Human Reproduction]] (HRP), [[Swedish International Development Cooperation Agency]] (Sida), [[United Nations Population Fund]] (UNFPA), [[Wellcome Trust]], and the [[World Bank][. | |
| ==== World Bank ==== | ==== World Bank ==== |
| |
| |
| He is part of the team that developed a new mechanism that allows countries to use World Bank financing to purchase [[COVID-19 vaccines]], beyond the fully donor-subsidized doses they are already receiving, through COVAX. He is co-chair of the [[Immunization Agenda 2030]] Financial Sustainability working group. | He is part of the team that developed a new mechanism that allows countries to use World Bank financing to purchase [[COVID-19 vaccines]], beyond the fully donor-subsidized doses they are already receiving, through COVAX. He is co-chair of the [[Immunization Agenda 2030]] Financial Sustainability working group. |
| | |
| | He also participated on the [[UHC2030]] Working Group on Sustainability, Transition from Aid and Health System Strengthening in 2017.((//First face to face meeting of the UHC2030 Working Group on Sustainability, Transition from Aid and Health System Strengthening.// (2017, March). UHC2030. https://web.archive.org/web/20210623044309/https://www.uhc2030.org/fileadmin/uploads/uhc2030/Documents/About_UHC2030/UHC2030_Working_Groups/2017_Transition_working_group_docs/Provisional_lst_of_participants_30-31_March_2017__1_.pdf)) |
| |
| ===== Other affiliations ===== | ===== Other affiliations ===== |
| * [[Centre for Health Economics and Policy Analysis]] | * [[Centre for Health Economics and Policy Analysis]] |
| * [[Harvard University]], Department of Health and Policy Management | * [[Harvard University]], Department of Health and Policy Management |
| | * [[Health Economics and Systems Analysis Group]] (HESA) |
| * [[London School of Economics and Political Science]] | * [[London School of Economics and Political Science]] |
| * [[McMaster Health Forum]] | * [[McMaster Health Forum]] |
| * [[Michael DeGroote School of Medicine]], [[McMaster University]] | * [[Michael DeGroote School of Medicine]], [[McMaster University]] |
| * [[Program in Policy Decision-Making]] | * [[Program in Policy Decision-Making]] |
| | * [[Public Health Foundation of India]] |
| * [[Queen's University]] | * [[Queen's University]] |
| * [[Royal Holloway, University of London]] | * [[Royal Holloway, University of London]] |
| * [[University of British Columbia]] | * [[University of British Columbia]] |
| | * [[University of Cape Town]] |
| * [[University of Geneva]] | * [[University of Geneva]] |
| * [[University of Toronto]] | * [[University of Toronto]] |
